KULIM: Abbott, one of the world’s leading healthcare companies, is investing US$60 million (RM192 million) to build a facility at the Kulim Hi-Tech Park (KHTP) to manufacture intraocular lens (IOLs) that are used to treat cataracts.
To continue reading the rest of the article, click here